Global Refractive Surgery Devices Market is expected to grow with the CAGR of 8.2% in the forecast period of 2022 to 2029. The years considered for study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/de/reports/global-refractive-surgery-devices-market
Global refractive surgery devices market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in global refractive surgery devices market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.
For instance:
- In July 2021, Johnson & Johnson Vision launched the VERITAS Vision System, next-generation phacoemulsification (phaco) system. This system is developed to look after three important areas: surgeon efficiency, patient safety, and comfort. This have increased company’s product portfolio.
- In January 2022, Alcon completed Acquisition of Ivantis, Inc., and bringing Hydrus Microstent into Its Global Surgical Portfolio. With this acquisition, the immediate integration of Ivantis associates helps ensure continuity of the business and relationships with existing customers. This transaction will further strengthen the company’s global surgical portfolio and help provide a platform for more growth in the glaucoma space and increase the revenue generation.
Johnson & Johnson Services Inc. is the dominating player in global refractive surgery devices market. The other key players existing in the market are Tracey Technologies, Bausch + Lomb Incorporated, BD, STAAR SURGICAL, SCHWIND eye-tech-solutions, Johnson & Johnson Services, Inc., Ophtec BV, Glaukos Corporation, Amplitude Laser, Reichert, Inc., NIDEK CO.,LTD., Ziemer Ophthalmic Systems, ROWIAK GmbH, MORA., Topcon Canada Inc.(A subsidiary Topcon Corporation), Rayner Intraocular Lenses Limited., iVIS Technologies, Alcon and among others
Johnson & Johnson Services Inc.
Johnson & Johnson Services Inc. is headquartered in New Jersey, U.S. and founded in the year 1886. The company focuses on improving accessibility and affordability, creating healthier communities, and put a healthy mind, body, and environment. The various products of the company include Consumer Health, Medical Devices, Pharmaceutical Products of which Medical Devices is the market focused category.
- In July 2021, Johnson & Johnson services inc., announced the launch of VERITAS Vision System, next-generation phacoemulsification (phaco) system which important for three areas: surgeon efficiency, patient safety, and comfort. This has increased the company’s product portfolio
The company has wide presence across South America, North America, South Asia, Oceania, East Asia, and Europe. The company also has various subsidiary such as Acclarent (U.S.), Actelion Pharmaceuticals US, Inc. (U.S.), Akros Medical, Inc (U.S.), ALZA Corporation (U.S.), Ethicon LLC (U.S.) among others.
Alcon
Alcon is headquartered in Geneva, Switzerland and founded in the year 1945. The eye care device company focuses on Surgical and Vision Care. The various products of the company include Contact Lenses & Solutions, Refractive Technology, Cataract Surgery, Vitreoretinal Surgery, Glaucoma of which Refractive Technology is the market focused category.
For instance,
- In January 2022, Alcon announced the European launch of the newest addition to its innovative portfolio of dry eye products Systane Complete Preservative-Free Lubricant Eye Drops, now in an easy-to-use, multi-dose bottle. This will strengthen the company's footprint in Europe and increase revenue generation
The company has presence across The Americas, Asia-Pacific, Europe, Middle East and Africa. The company also has various subsidiaries including Alcon Laboratorios Argentina S.A.(Switzerland), Alcon Laboratories (Australia) Pty Ltd (Switzerland), Alcon Ophthalmika GmbH (Switzerland), Alcon Laboratories Belgium BVBA (Switzerland), N.V. Alcon S.A. (Switzerland), among others.
STAAR SURGICAL
STAAR SURGICAL is headquartered in California, U.S. and founded in the year 1982. The company focuses on designing, developing, and manufacturing of implantable lenses for the eye. The various products of the company include Refractive Solutions, Cataract Solutions of which Refractive Solutions is the market focused category.
For instance,
- In April 2020, STAAR SURGICAL began its commercialization of the EVO Viva lens, which is used for patients who have problems with near vision and at the age of about 40 to 50. This has helped the company to reach out to the maximum population in the country and increased the company’s revenue from it
The company has presence across Japan, Germany, Spain, Canada, U.K., Singapore. The company has various subsidiaries including STAAR Surgical UK LTD, (U.K), STAAR Surgical AG (Switzerland), STAAR Japan Inc. (Japan), STAAR Surgical China Co.,Ltd. (China), STAAR Surgical India Private Limited (India).
